NCNA -8% on ESMO data: https://globenewswire.com/news-release/2018/10/21/1624356/0/en/NuCana-Reports-Additional-Promising-Clinical-Data-on-NUC-1031-Acelarin-as-Front-Line-Treatment-of-Advanced-Biliary-Tract-Cancer-at-ESMO-2018.html